{"id":83217,"date":"2026-06-24T14:38:08","date_gmt":"2026-06-24T12:38:08","guid":{"rendered":"https:\/\/elithair.com\/tr\/?p=83217"},"modified":"2026-06-24T14:38:08","modified_gmt":"2026-06-24T12:38:08","slug":"clascoterone-sac-dokulmesi","status":"publish","type":"post","link":"https:\/\/elithair.com\/tr\/clascoterone-sac-dokulmesi\/","title":{"rendered":"Sa\u00e7 d\u00f6k\u00fclmesi ilac\u0131 Clascoterone: Etkisi, \u00e7al\u0131\u015fmalar ve 2026 durumu"},"content":{"rendered":"\n<div style=\"background:#f3f7fc;border-left:5px solid #0079F1;border-radius:10px;padding:20px 22px;margin-bottom:28px\">\n<p style=\"margin:0 0 10px;color:#013366;font-weight:700;font-size:18px\">K\u0131sa yan\u0131t<\/p>\n<p style=\"margin:0 0 14px;color:#2e3033;font-size:16px;line-height:1.6\">Sa\u00e7 d\u00f6k\u00fclmesi etkin maddesi Clascoterone (Cortexolone-17&alpha;-propionat), sa\u00e7 folik\u00fcl\u00fcndeki androjen resept\u00f6r\u00fcn\u00fc do\u011frudan bloke eden topikal bir antiandrojendir. <strong>Winlevi<\/strong> (%1) ad\u0131yla bir akne kremi olarak ruhsatl\u0131d\u0131r (FDA 2020, EMA Ekim 2025). Kal\u0131tsal sa\u00e7 d\u00f6k\u00fclmesine kar\u015f\u0131 ise <strong>Breezula<\/strong> (%5 \u00e7\u00f6zelti) olarak ara\u015ft\u0131r\u0131lmaktad\u0131r. Haziran 2026 itibar\u0131yla Breezula Almanya ve AB&#8217;de ne bulunmakta ne de re\u00e7ete edilebilmektedir.<\/p>\n<ul style=\"margin:0;padding-left:20px;color:#2e3033;font-size:15px;line-height:1.7\">\n<li><strong>Etken madde s\u0131n\u0131f\u0131:<\/strong> topikal antiandrojen (androjen resept\u00f6r\u00fc antagonisti)<\/li>\n<li><strong>E\u015f anlaml\u0131lar:<\/strong> Cortexolone 17alpha-propionate, CB-03-01, CAS 19608-29-8<\/li>\n<li><strong>Hedef kitle:<\/strong> hafif ila orta d\u00fczeyde androjenetik alopesisi (AGA) olan erkekler<\/li>\n<li><strong>Finasterid&#8217;den fark\u0131:<\/strong> Finasterid&#8217;in aksine Clascoterone yaln\u0131zca folik\u00fclde lokal etki g\u00f6sterir ve v\u00fccudun geri kalan\u0131ndaki DHT d\u00fczeyini d\u00fc\u015f\u00fcrmez.<\/li>\n<li><strong>Durum (Haziran 2026):<\/strong> Faz III tamamland\u0131, FDA ruhsat ba\u015fvurusu 2027 ba\u015f\u0131 i\u00e7in planlan\u0131yor, DE\/AB&#8217;de mevcut de\u011fil<\/li>\n<\/ul>\n<\/div>\n\n\n\n<div style=\"background:#fff;border:1px solid #e3e8ef;border-left:5px solid #013366;border-radius:10px;padding:16px 18px;margin-bottom:24px\">\n<p style=\"margin:0 0 6px;color:#013366;font-weight:700;font-size:15px\">Uzman de\u011ferlendirmesi &middot; Elithair Yay\u0131n Kurulu<\/p>\n<p style=\"margin:0;color:#2e3033;font-size:14px;line-height:1.65\">Bu rehber, Elithair yay\u0131n kurulu taraf\u0131ndan resmi kurum belgelerine (FDA, EMA), yay\u0131mlanm\u0131\u015f bilimsel literat\u00fcre ve \u00fcreticinin \u00e7al\u0131\u015fma a\u00e7\u0131klamalar\u0131na dayan\u0131larak haz\u0131rlanm\u0131\u015f ve t\u0131bbi a\u00e7\u0131dan g\u00f6zden ge\u00e7irilmi\u015ftir. Sa\u00e7 d\u00f6k\u00fclmesine kar\u015f\u0131 Clascoterone (Breezula) deneysel, hen\u00fcz ruhsatland\u0131r\u0131lmam\u0131\u015f bir etken madde oldu\u011fundan, etkinlik ve g\u00fcvenli\u011fe ili\u015fkin t\u00fcm ifadeler temkinli bi\u00e7imde ve ilgili \u00e7al\u0131\u015fma ba\u011flam\u0131yla birlikte de\u011ferlendirilmi\u015ftir. <strong>Durum: Haziran 2026.<\/strong> Bu yaz\u0131 t\u0131bbi dan\u0131\u015fmanl\u0131\u011f\u0131n yerini tutmaz.<\/p>\n<\/div>\n\n\n\n<p class=\"wp-block-paragraph\">Genetik kaynakl\u0131 sa\u00e7 d\u00f6k\u00fclmesine kar\u015f\u0131 yeni bir umuttan s\u00f6z edildi\u011finde forumlarda, Reddit&#8217;te ve YouTube&#8217;da hep ayn\u0131 isim \u00f6ne \u00e7\u0131k\u0131yor: Clascoterone. Bu rehber, etken maddeyi serinkanl\u0131 bi\u00e7imde ele al\u0131yor; \u00e7al\u0131\u015fmalar\u0131n ger\u00e7ekte ne g\u00f6sterdi\u011fini, s\u0131n\u0131rlar\u0131n nerede oldu\u011funu ve bu maddeyi \u015fu anda edinip edinemeyece\u011finizi anlat\u0131yor.<\/p>\n\n\n\n<h2 id=\"h-clascoterone-nedir\" class=\"wp-block-heading\">Clascoterone nedir?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Clascoterone, kimyasal olarak Cortexolone-17\u03b1-propionat (\u0130ngilizce INN: Cortexolone 17alpha-propionate, geli\u015ftirme ad\u0131 CB-03-01, CAS 19608-29-8) olarak adland\u0131r\u0131lan topikal bir antiandrojendir. Do\u011frudan sa\u00e7l\u0131 deriye uygulan\u0131r ve erkeklerde en s\u0131k g\u00f6r\u00fclen sa\u00e7 d\u00f6k\u00fclmesi olan androjenetik alopesinin hormonal tetikleyicisini hedef al\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Yap\u0131sal olarak progesteron ve 11-deoksikortizolden t\u00fcretilen sentetik bir pregnan steroididir. Yani bir steroittir, ancak bir kortikosteroit de\u011fildir: kortizon preparat\u0131 gibi de\u011fil, antiandrojen olarak etki eder. Etken madde, Cassiopea S.p.A. (\u0130talya) taraf\u0131ndan geli\u015ftirilmi\u015ftir; bug\u00fcn Cosmo Pharmaceuticals \u00e7at\u0131s\u0131 alt\u0131nda yer almaktad\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">As\u0131l \u00f6nemli nokta \u015fu: Clascoterone, folik\u00fcl\u00fcn dermal papilla h\u00fccrelerindeki androjen resept\u00f6r\u00fcn\u00fc yar\u0131\u015fmac\u0131 bi\u00e7imde bloke eder. Orada ba\u011flanma b\u00f6lgesi i\u00e7in dihidrotestosteron (DHT) ile rekabet eder. B\u00f6ylece DHT&#8217;nin y\u00f6nlendirdi\u011fi folik\u00fcl minyat\u00fcrizasyonu, v\u00fccudun geri kalan\u0131ndaki hormon \u00fcretimini de\u011fi\u015ftirmeden frenlenir.<\/p>\n\n\n\n<div style=\"background:#fff;border:1px solid #e3e8ef;border-radius:10px;padding:16px 18px;margin:8px 0 24px\">\n<p style=\"margin:0;color:#2e3033;font-size:15px;line-height:1.65\"><strong style=\"color:#013366\">K\u0131saca a\u00e7\u0131klamas\u0131:<\/strong> DHT, erkeklik hormonu testosteronun daha etkili formudur ve kal\u0131tsal sa\u00e7 d\u00f6k\u00fclmesinin ba\u015fl\u0131ca nedeni olarak kabul edilir. Duyarl\u0131 folik\u00fcllerin androjen resept\u00f6r\u00fcne ba\u011flan\u0131r ve bu folik\u00fclleri y\u0131llar i\u00e7inde k\u00fc\u00e7\u00fclt\u00fcr. Bu konuda daha fazlas\u0131 i\u00e7in <a href=\"https:\/\/elithair.com\/tr\/genetik-sac-dokulmesi-nasil-engellenir\/\">androjenetik alopesi<\/a> yaz\u0131m\u0131za bakabilirsiniz.<\/p>\n<\/div>\n\n\n\n<h2 id=\"h-winlevi-breezula-ve-clascoterone-aradaki-fark\" class=\"wp-block-heading\">Winlevi, Breezula ve Clascoterone: aradaki fark<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Winlevi, Breezula ve Clascoterone ayn\u0131 etken maddenin farkl\u0131 sunumlar\u0131n\u0131 ifade eder: Clascoterone saf etken maddedir (INN), Winlevi ruhsatl\u0131 akne kremi, Breezula ise deneysel sa\u00e7 d\u00f6k\u00fclmesi \u00e7\u00f6zeltisidir. Konsantrasyon, ta\u015f\u0131y\u0131c\u0131 (vehik\u00fcl) ve endikasyon a\u00e7\u0131s\u0131ndan farkl\u0131l\u0131k g\u00f6sterirler; tedavi a\u00e7\u0131s\u0131ndan belirleyici olan tam da budur.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Winlevi, y\u00fcz aknesi i\u00e7in bir kremde %1 Clascoterone i\u00e7erir. Breezula ise sa\u00e7l\u0131 deriye n\u00fcfuz edecek \u015fekilde form\u00fcle edilmi\u015f %5&#8217;lik bir \u00e7\u00f6zeltidir. EMA \u00fcr\u00fcn sayfas\u0131na g\u00f6re Winlevi 17 Ekim 2025&#8217;te AB&#8217;de ruhsatland\u0131r\u0131ld\u0131; Breezula&#8217;n\u0131n ise sa\u00e7 d\u00f6k\u00fclmesine kar\u015f\u0131 herhangi bir ruhsat\u0131 yoktur (Haziran 2026 durumu).<\/p>\n\n\n\n<style data-wp-block-html=\"css\">\n@media(max-width: 600px) {\n.htk-tablewrap{overflow:visible !important}\n  .htk-tablewrap .htk-table,\n  .htk-table{min-width:0 !important;box-shadow:none !important;border-radius:0 !important;overflow:visible !important}\n  .htk-table thead{position:absolute !important;width:1px;height:1px;overflow:hidden;clip:rect(0 0 0 0);white-space:nowrap}\n.htk-table {background: transparent;}\n  .htk-table,.htk-table tbody,.htk-table tfoot,.htk-table tr,.htk-table td{display:block;width:100%}\n  .htk-table tr{\n    margin:0 0 16px;border:1px solid var(--line,rgba(13,44,84,.10));\n    border-radius:var(--r-sm,14px);overflow:hidden;background:#fff;\n    box-shadow:var(--sh-md,0 18px 44px -26px rgba(8,28,58,.40));\n  }\n  .htk-table tr:last-child{margin-bottom:0}\n  .htk-table tr:nth-child(even) td,\n  .htk-table tr:nth-child(odd) td{background:transparent}\n  .htk-table td{\n    border-top:0 !important;border-bottom:1px solid rgba(13,44,84,.08);\n    padding:11px 16px;text-align:left;white-space:normal !important;\n  }\n.htk-table.mob-two-column td{\ntext-align:right;\n}\n  .htk-table td:last-child{border-bottom:0}\n  .htk-table td:empty{display:none}\n  .htk-table td::before{\n    content:attr(data-label);display:block;\n    font-size:11.5px;font-weight:700;letter-spacing:.04em;text-transform:uppercase;\n    color:var(--sky-strong,#3f74c0);margin-bottom:3px;\n  }\n.htk-table.mob-two-column td::before{position:absolute;}\n  .htk-table td:first-child{\n    background:var(--navy,#0d2c54) !important;color:#fff !important;\n    font-size:16px;font-weight:700;padding:13px 16px;text-align:left;\n  }\n  .htk-table td:first-child::before{display:none}\n  .htk-table td:first-child strong{color:#fff}\n  .htk-table td.eli:not(:first-child){color:var(--navy,#0d2c54);font-weight:800}\n  .htk-table td.save:not(:first-child){color:#1e9e63;font-weight:800}\n  .htk-table td.eli:not(:first-child)::before,\n  .htk-table td.save:not(:first-child)::before{color:var(--sky-strong,#3f74c0)}\n  .htk-band--navy .htk-table td:not(:first-child){color:var(--ink,#13233b)}\n  .htk-band--navy .htk-table td:not(:first-child) strong{color:inherit}\n  .htk-band--navy .htk-table td.eli:not(:first-child){color:var(--navy,#0d2c54)}\n  .htk-band--navy .htk-table td.save:not(:first-child){color:#1e9e63}\n  .htk-band--navy .htk-table tfoot td{background:transparent}\n  .htk-table tfoot tr{border:2px solid var(--sky-strong,#3f74c0)}\n.htk-table caption {display:block;}\n}\n<\/style>\n\n<script data-wp-block-html=\"js\">\n(function(){\n  function labelHtkTables(){\n    document.querySelectorAll('.htk-table').forEach(function(table){\n      var heads = table.querySelectorAll('thead th');\n      if(!heads.length) return;\n      var labels = Array.prototype.map.call(heads,function(th){return th.textContent.trim();});\n      table.querySelectorAll('tbody tr, tfoot tr').forEach(function(row){\n        Array.prototype.forEach.call(row.children,function(cell,i){\n          if(labels[i] && !cell.getAttribute('data-label')){\n            cell.setAttribute('data-label', labels[i]);\n          }\n        });\n      });\n    });\n  }\n  if(document.readyState==='loading'){\n    document.addEventListener('DOMContentLoaded', labelHtkTables);\n  }else{ labelHtkTables(); }\n})();\n<\/script>\n\n<div style=\"overflow-x:auto;margin-bottom:28px\"><table class=\"htk-table\" style=\"min-width:640px;width:100%;border-collapse:collapse;font-size:15px\"><thead><tr style=\"background:#013366;color:#fff\"><th style=\"padding:11px;text-align:left\">Ad\u0131<\/th><th style=\"padding:11px;text-align:left\">T\u00fcr \/ Konsantrasyon<\/th><th style=\"padding:11px;text-align:left\">Endikasyon<\/th><th style=\"padding:11px;text-align:left\">Ruhsat durumu (Haziran 2026)<\/th><\/tr><\/thead><tbody>\n<tr style=\"border-bottom:1px solid #e3e8ef\"><td style=\"padding:11px\"><strong>Clascoterone<\/strong><\/td><td style=\"padding:11px\">Etken madde (INN) = Cortexolone-17\u03b1-propionat<\/td><td style=\"padding:11px\">topikal antiandrojen<\/td><td style=\"padding:11px\">etken madde, markaya\/endikasyona g\u00f6re de\u011fi\u015fir<\/td><\/tr>\n<tr style=\"border-bottom:1px solid #e3e8ef;background:#f7fafd\"><td style=\"padding:11px\"><strong>Winlevi<\/strong><\/td><td style=\"padding:11px\">Krem, %1<\/td><td style=\"padding:11px\">Akne vulgaris (12 ya\u015f ve \u00fczeri)<\/td><td style=\"padding:11px\">ruhsatl\u0131: FDA A\u011fustos 2020, EMA Ekim 2025 (ek izleme alt\u0131nda)<\/td><\/tr>\n<tr style=\"border-bottom:1px solid #e3e8ef\"><td style=\"padding:11px\"><strong>Breezula<\/strong><\/td><td style=\"padding:11px\">topikal \u00e7\u00f6zelti (sa\u00e7l\u0131 deri), %5<\/td><td style=\"padding:11px\">androjenetik alopesi (AGA)<\/td><td style=\"padding:11px\"><strong>ruhsats\u0131z<\/strong>, Faz III tamamland\u0131, FDA ba\u015fvurusu 2027 ba\u015f\u0131 i\u00e7in planland\u0131<\/td><\/tr>\n<\/tbody><\/table>\n<p style=\"font-size:13px;color:#6b7280;margin:8px 0 0\">Ayn\u0131 etken madde, farkl\u0131 markalar ve endikasyonlar. Kaynaklar: EMA Winlevi-EPAR; DermNet NZ; Cosmo Pharmaceuticals.<\/p>\n<\/div>\n\n\n\n<h2 id=\"h-clascoterone-sac-dokulmesine-nasil-etki-eder\" class=\"wp-block-heading\">Clascoterone sa\u00e7 d\u00f6k\u00fclmesine nas\u0131l etki eder?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Clascoterone&#8217;un etkisi, androjen resept\u00f6r\u00fcndeki antagonizme dayan\u0131r: etken madde, dermal papilla h\u00fccrelerindeki resept\u00f6re yar\u0131\u015fmac\u0131 bi\u00e7imde ba\u011flan\u0131r ve orada DHT ile testosteronun, androjenetik alopeside folik\u00fcllerin k\u00fc\u00e7\u00fclmesine yol a\u00e7an genleri etkinle\u015ftirmesini engeller. Yani folik\u00fcl\u00fcn kendisinde etki g\u00f6steren lokal bir hormon blokeridir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In vitro ortamda Clascoterone, androjen y\u00f6nlendirmeli transkripsiyonu Finasterid&#8217;e benzer etkinlikte bask\u0131lar ve DHT ile uyar\u0131lan skalp papilla h\u00fccrelerinde IL-6 sentezini, antiandrojen etken madde Enzalutamid&#8217;den daha g\u00fc\u00e7l\u00fc bi\u00e7imde azaltm\u0131\u015ft\u0131r (Rosette ve ark. 2019, Journal of Drugs in Dermatology). B\u00f6ylece minyat\u00fcrizasyonun biyolojik tetikleyicisine do\u011frudan m\u00fcdahale eder.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Etki b\u00fcy\u00fck \u00f6l\u00e7\u00fcde lokal kal\u0131r. Deride ve plazmada Clascoterone, esterazlar arac\u0131l\u0131\u011f\u0131yla h\u0131zla inaktif metabolit Cortexolone&#8217;a par\u00e7alan\u0131r. Mazzetti ve ark. (2019) verilerine g\u00f6re 14 g\u00fcnl\u00fck s\u00fcrekli kullan\u0131mdan sonra ortalama Cmax de\u011feri 4,4 ila 4,6 ng\/ml d\u00fczeyindeydi; bu aktif y\u0131k\u0131m yolu, sistemik antiandrojen etkiyi belirgin bi\u00e7imde s\u0131n\u0131rlar.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large is-resized\" style=\"max-width:560px;margin-left:auto;margin-right:auto\"><img loading=\"lazy\" decoding=\"async\" width=\"1536\" height=\"1024\" src=\"https:\/\/elithair.com\/tr\/wp-content\/uploads\/sites\/10\/2026\/06\/wirkmechanismus_follikel__tr.png\" alt=\"\u0130ll\u00fcstrasyon: Clascoterone sa\u00e7 folik\u00fcl\u00fcndeki androjen resept\u00f6r\u00fcn\u00fc bloke ederek DHT'nin yerini al\u0131r\" class=\"wp-image-83214\" style=\"width:560px;max-width:100%;height:auto\" srcset=\"https:\/\/elithair.com\/tr\/wp-content\/uploads\/sites\/10\/2026\/06\/wirkmechanismus_follikel__tr.png 1536w, https:\/\/elithair.com\/tr\/wp-content\/uploads\/sites\/10\/2026\/06\/wirkmechanismus_follikel__tr-300x200.png 300w, https:\/\/elithair.com\/tr\/wp-content\/uploads\/sites\/10\/2026\/06\/wirkmechanismus_follikel__tr-1024x683.png 1024w, https:\/\/elithair.com\/tr\/wp-content\/uploads\/sites\/10\/2026\/06\/wirkmechanismus_follikel__tr-768x512.png 768w\" sizes=\"(max-width: 767px) 100vw, 660px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\">Bu mekanizma, etken maddenin yerle\u015fik ila\u00e7lardan fark\u0131n\u0131 a\u00e7\u0131klar: Finasterid, 5\u03b1-red\u00fcktaz enzimini sistemik olarak bask\u0131lar ve b\u00f6ylece t\u00fcm v\u00fccuttaki DHT d\u00fczeyini d\u00fc\u015f\u00fcr\u00fcr. Clascoterone ise yaln\u0131zca folik\u00fcldeki resept\u00f6r\u00fc bloke eder; kandaki DHT d\u00fczeyi de\u011fi\u015fmeden kal\u0131r. Minoksidil ise hormon sistemine hi\u00e7 dokunmaz; bunun yerine b\u00fcy\u00fcme evresini uzat\u0131r ve kan dola\u015f\u0131m\u0131n\u0131 destekler.<\/p>\n\n\n\n<h2 id=\"h-clascoterone-ile-ilgili-calismalar-ne-gosteriyor\" class=\"wp-block-heading\">Clascoterone ile ilgili \u00e7al\u0131\u015fmalar ne g\u00f6steriyor?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Clascoterone ile ilgili \u00e7al\u0131\u015fmalar, androjenetik alopesiye kar\u015f\u0131 istatistiksel olarak anlaml\u0131 etkiler g\u00f6steriyor; ancak bunlar a\u011f\u0131rl\u0131kl\u0131 olarak hakem denetiminden ge\u00e7mi\u015f tam yay\u0131nlardan de\u011fil, \u015firket bas\u0131n a\u00e7\u0131klamalar\u0131ndan geliyor (Haziran 2026 durumu). Belirleyici son nokta, TAHC (Target Area Hair Count) de\u011feridir: tedavi edilen b\u00f6lgedeki santimetrekare ba\u015f\u0131na vellus olmayan k\u0131l say\u0131s\u0131.<\/p>\n\n\n\n<h3 id=\"h-erkeklerde-faz-ii-mutlak-kil-sayilari\" class=\"wp-block-heading\">Erkeklerde Faz II: mutlak k\u0131l say\u0131lar\u0131<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Clascoterone&#8217;a ili\u015fkin Faz II \u00e7al\u0131\u015fmas\u0131 (400&#8217;\u00fcn \u00fczerinde erkek, 18 ila 55 ya\u015f, hafif ila orta d\u00fczeyde AGA, Almanya&#8217;daki \u00e7al\u0131\u015fma merkezleri, 12 ay), \u00e7e\u015fitli konsantrasyonlar\u0131 ta\u015f\u0131y\u0131c\u0131yla (vehik\u00fcl) kar\u015f\u0131la\u015ft\u0131rd\u0131. Cassiopea bas\u0131n a\u00e7\u0131klamas\u0131na g\u00f6re (Nisan 2019) t\u00fcm aktif kollar anlaml\u0131 bi\u00e7imde \u00fcst\u00fcnd\u00fc; say\u0131sal olarak en g\u00fc\u00e7l\u00fcs\u00fc, g\u00fcnde iki kez %7,5 ile +14,3 k\u0131l\/cm\u00b2 oldu.<\/p>\n\n\n\n<div style=\"overflow-x:auto;margin-bottom:28px\"><table class=\"htk-table\" style=\"min-width:560px;width:100%;border-collapse:collapse;font-size:15px\"><thead><tr style=\"background:#013366;color:#fff\"><th style=\"padding:11px;text-align:left\">Konsantrasyon \/ Uygulama<\/th><th style=\"padding:11px;text-align:left\">TAHC vs. vehik\u00fcl<\/th><th style=\"padding:11px;text-align:left\">K\u0131l geni\u015fli\u011fi (TAHW)<\/th><th style=\"padding:11px;text-align:left\">p-de\u011feri<\/th><\/tr><\/thead><tbody>\n<tr style=\"border-bottom:1px solid #e3e8ef\"><td style=\"padding:11px\">%2,5 g\u00fcnde iki kez<\/td><td style=\"padding:11px\">+10,2 k\u0131l\/cm\u00b2<\/td><td style=\"padding:11px\">+521,1 \u00b5m<\/td><td style=\"padding:11px\">0,0087<\/td><\/tr>\n<tr style=\"border-bottom:1px solid #e3e8ef;background:#f7fafd\"><td style=\"padding:11px\">%5,0 g\u00fcnde iki kez<\/td><td style=\"padding:11px\">+13,8 k\u0131l\/cm\u00b2<\/td><td style=\"padding:11px\">+615,0 \u00b5m<\/td><td style=\"padding:11px\">0,0006<\/td><\/tr>\n<tr style=\"border-bottom:1px solid #e3e8ef\"><td style=\"padding:11px\"><strong>%7,5 g\u00fcnde iki kez<\/strong><\/td><td style=\"padding:11px\"><strong>+14,3 k\u0131l\/cm\u00b2<\/strong><\/td><td style=\"padding:11px\">+762,5 \u00b5m<\/td><td style=\"padding:11px\">0,0003<\/td><\/tr>\n<tr style=\"border-bottom:1px solid #e3e8ef;background:#f7fafd\"><td style=\"padding:11px\">%7,5 g\u00fcnde bir kez<\/td><td style=\"padding:11px\">+12,7 k\u0131l\/cm\u00b2<\/td><td style=\"padding:11px\">+658,8 \u00b5m<\/td><td style=\"padding:11px\">0,0016<\/td><\/tr>\n<\/tbody><\/table>\n<p style=\"font-size:13px;color:#6b7280;margin:8px 0 0\">Erkeklerde Faz II verileri, 12 ay. Kaynak: Cassiopea bas\u0131n a\u00e7\u0131klamas\u0131 Nisan 2019 (hakem denetiminden ge\u00e7mi\u015f tam yay\u0131n de\u011fildir).<\/p>\n<\/div>\n\n\n\n<h3 id=\"h-erkeklerde-faz-iii-scalp-1-ve-scalp-2\" class=\"wp-block-heading\">Erkeklerde Faz III (SCALP 1 ve SCALP 2)<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Clascoterone&#8217;a ili\u015fkin Faz III \u00e7al\u0131\u015fmas\u0131nda (Breezula %5 \u00e7\u00f6zelti) iki \u00e7al\u0131\u015fmada (SCALP 1 ve SCALP 2, ABD ve Avrupa&#8217;da 51 merkez) 1.465 erkek randomize edildi. Cosmo&#8217;nun topline verilerine g\u00f6re (Aral\u0131k 2025) SCALP 1, plaseboya k\u0131yasla +%539, SCALP 2 ise +%168 g\u00f6reli TAHC iyile\u015fmesine ula\u015ft\u0131 (her ikisinde de p &lt; 0,05).<\/p>\n\n\n\n<div style=\"background:#fff8ed;border-left:5px solid #f0a500;border-radius:8px;padding:16px 18px;margin:4px 0 22px\">\n<p style=\"margin:0;color:#2e3033;font-size:15px;line-height:1.65\"><strong style=\"color:#013366\">Say\u0131lar\u0131 do\u011fru de\u011ferlendirmek i\u00e7in \u00f6nemli:<\/strong> %539 ve %168, plaseboya k\u0131yasla <em>g\u00f6reli<\/em> iyile\u015fmelerdir; mutlak sa\u00e7 yo\u011funlu\u011fu de\u011fildir. Plasebo grubu neredeyse hi\u00e7 de\u011fi\u015fmiyorsa, k\u00fc\u00e7\u00fck mutlak farklar bile b\u00fcy\u00fck y\u00fczde de\u011ferleri verir. Mutlak Faz III k\u0131l say\u0131lar\u0131, Haziran 2026&#8217;ya kadar hakem denetiminden ge\u00e7mi\u015f bi\u00e7imde yay\u0131mlanmad\u0131. Mutlak Faz II de\u011feri yakla\u015f\u0131k +14 k\u0131l\/cm\u00b2 d\u00fczeyindeydi.<\/p>\n<\/div>\n\n\n\n<p class=\"wp-block-paragraph\">12 ayl\u0131k veriler (Nisan 2026), Cosmo&#8217;ya g\u00f6re, kesintisiz tedavi g\u00f6ren erkeklerin, 6 ay\u0131n ard\u0131ndan ta\u015f\u0131y\u0131c\u0131ya (vehik\u00fcl) ge\u00e7enlere k\u0131yasla %239 daha y\u00fcksek bir TAHC art\u0131\u015f\u0131na ula\u015ft\u0131\u011f\u0131n\u0131 g\u00f6steriyor. CEO Giovanni Di Napoli, bu de\u011ferlerin 6 ayl\u0131k rakamlarla do\u011frudan kar\u015f\u0131la\u015ft\u0131r\u0131lamayaca\u011f\u0131n\u0131 bizzat vurgulad\u0131. G\u00fcvenlik profili, vehik\u00fcl d\u00fczeyinde kald\u0131.<\/p>\n\n\n\n<h3 id=\"h-clascoterone-kadinlarda-da-etki-eder-mi\" class=\"wp-block-heading\">Clascoterone kad\u0131nlarda da etki eder mi?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Clascoterone&#8217;un kad\u0131nlarda etki edip etmedi\u011fi belirsizdir: ilk ipu\u00e7lar\u0131 yeterince kan\u0131tlanmam\u0131\u015ft\u0131r. 293 kad\u0131nla yap\u0131lan bir Faz II \u00e7al\u0131\u015fmas\u0131nda, genel pop\u00fclasyonda vehik\u00fcle kar\u015f\u0131 anlaml\u0131 bir \u00fcst\u00fcnl\u00fck g\u00f6r\u00fclmedi. Yaln\u0131zca %5 Clascoterone kullanan 30 ya\u015f alt\u0131 alt grupta TAHC fark\u0131 anlaml\u0131yd\u0131 (p = 0,0391, Cassiopea Eyl\u00fcl 2021).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ancak bu alt grup istatistiksel kan\u0131t g\u00fcc\u00fc i\u00e7in tasarlanmam\u0131\u015ft\u0131; olgu say\u0131s\u0131 genel bir \u00f6neri i\u00e7in yeterli de\u011fildir. Kad\u0131nlara y\u00f6nelik ayr\u0131 bir Faz III program\u0131 \u015fimdiye dek duyurulmad\u0131 (Haziran 2026 durumu). Bu nedenle kad\u0131nlar i\u00e7in etken madde deneysel ve kan\u0131tlanmam\u0131\u015f say\u0131l\u0131r. Konuya dair daha fazlas\u0131 i\u00e7in <a href=\"https:\/\/elithair.com\/tr\/kadinlarda-erkek-tipi-sac-dokulmesi-nedenleri\/\">kad\u0131nlarda sa\u00e7 d\u00f6k\u00fclmesi<\/a> yaz\u0131m\u0131za bakabilirsiniz.<\/p>\n\n\n\n<h2 id=\"h-clascoterone-un-yan-etkileri-nelerdir\" class=\"wp-block-heading\">Clascoterone&#8217;un yan etkileri nelerdir?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Clascoterone&#8217;un yan etkileri a\u011f\u0131rl\u0131kl\u0131 olarak lokaldir: uygulama b\u00f6lgesinde k\u0131zar\u0131kl\u0131k, pullanma ve ka\u015f\u0131nt\u0131; akne ruhsat \u00e7al\u0131\u015fmalar\u0131nda bu, vehik\u00fcl d\u00fczeyindeydi. Sistemik olarak etken madde \u015fimdiye dek b\u00fcy\u00fck \u00f6l\u00e7\u00fcde dikkat \u00e7ekmedi. Ancak AGA&#8217;da sa\u00e7l\u0131 derinin uzun s\u00fcreli kullan\u0131m\u0131na dair uzun d\u00f6nem verileri hen\u00fcz eksik (Haziran 2026 durumu).<\/p>\n\n\n\n<div style=\"overflow-x:auto;margin-bottom:24px\"><table class=\"htk-table\" style=\"min-width:480px;width:100%;border-collapse:collapse;font-size:15px\"><thead><tr style=\"background:#013366;color:#fff\"><th style=\"padding:11px;text-align:left\">Lokal reaksiyon<\/th><th style=\"padding:11px;text-align:left\">Clascoterone %1<\/th><th style=\"padding:11px;text-align:left\">Vehik\u00fcl<\/th><\/tr><\/thead><tbody>\n<tr style=\"border-bottom:1px solid #e3e8ef\"><td style=\"padding:11px\">K\u0131zar\u0131kl\u0131k (eritem)<\/td><td style=\"padding:11px\">%12,2<\/td><td style=\"padding:11px\">%15,4<\/td><\/tr>\n<tr style=\"border-bottom:1px solid #e3e8ef;background:#f7fafd\"><td style=\"padding:11px\">Pullanma \/ kuruluk<\/td><td style=\"padding:11px\">%10,5<\/td><td style=\"padding:11px\">%10,4<\/td><\/tr>\n<tr style=\"border-bottom:1px solid #e3e8ef\"><td style=\"padding:11px\">Ka\u015f\u0131nt\u0131 (pruritus)<\/td><td style=\"padding:11px\">%7,7<\/td><td style=\"padding:11px\">%8,2<\/td><\/tr>\n<tr style=\"border-bottom:1px solid #e3e8ef;background:#f7fafd\"><td style=\"padding:11px\">Yanma \/ batma<\/td><td style=\"padding:11px\">%4,2<\/td><td style=\"padding:11px\">%4,3<\/td><\/tr>\n<tr style=\"border-bottom:1px solid #e3e8ef\"><td style=\"padding:11px\">\u00d6dem<\/td><td style=\"padding:11px\">%3,6<\/td><td style=\"padding:11px\">%3,5<\/td><\/tr>\n<\/tbody><\/table>\n<p style=\"font-size:13px;color:#6b7280;margin:8px 0 0\">Winlevi akne \u00e7al\u0131\u015fmas\u0131ndan lokal reaksiyonlar (%1 krem, 12 hafta). Kaynak: FDA etiketi \/ DailyMed.<\/p>\n<\/div>\n\n\n\n<p class=\"wp-block-paragraph\">A\u00e7\u0131k bir nokta HPA ekseni (hipotalamus-hipofiz-b\u00f6brek\u00fcst\u00fc bezi sistemi). Winlevi verilerinde, 14 g\u00fcn\u00fcn ard\u0131ndan yeti\u015fkinlerin %5&#8217;inde ve gen\u00e7lerin %9&#8217;unda ge\u00e7ici bir HPA bask\u0131lanmas\u0131 g\u00f6r\u00fcld\u00fc (Mazzetti ve ark. 2019); t\u00fcm vakalar, kullan\u0131m\u0131n b\u0131rak\u0131lmas\u0131ndan sonraki 4 hafta i\u00e7inde normale d\u00f6nd\u00fc. %5&#8217;lik \u00e7\u00f6zeltinin sa\u00e7l\u0131 deride aylar ila y\u0131llar s\u00fcren kullan\u0131m\u0131 i\u00e7in yeterli uzun d\u00f6nem verileri eksiktir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ayr\u0131ca Winlevi etiketinde, tedavi edilenlerin %5&#8217;inde potasyum de\u011ferlerinde y\u00fckselmeye do\u011fru bir kayma g\u00f6zlemlendi (vehik\u00fcl alt\u0131nda %4&#8217;e kar\u015f\u0131l\u0131k); klinik anlam\u0131 belirsizdir. Etiket bilgisine g\u00f6re etken madde gebelik ve emzirme d\u00f6neminde, 12 ya\u015f alt\u0131 \u00e7ocuklarda ve 65 ya\u015f ve \u00fczeri ki\u015filerde kontrendikedir. Dolay\u0131s\u0131yla Clascoterone yan etkisiz olarak nitelendirilemez.<\/p>\n\n\n\n<h2 id=\"h-clascoterone-vs-finasterid-vs-minoksidil\" class=\"wp-block-heading\">Clascoterone vs. Finasterid vs. Minoksidil<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Clascoterone, Finasterid ve Minoksidil farkl\u0131 noktalardan etki eder: Clascoterone androjen resept\u00f6r\u00fcn\u00fc lokal olarak bloke eder, Finasterid DHT d\u00fczeyini sistemik olarak d\u00fc\u015f\u00fcr\u00fcr, Minoksidil ise hormona m\u00fcdahale etmeden b\u00fcy\u00fcmeyi destekler. Bu \u00fc\u00e7 maddenin tek bir \u00e7al\u0131\u015fmadan do\u011frudan kafa kafaya etkinlik kar\u015f\u0131la\u015ft\u0131rmas\u0131 \u015fimdiye dek bulunmuyor.<\/p>\n\n\n\n<div style=\"overflow-x:auto;margin-bottom:28px\"><table class=\"htk-table\" style=\"min-width:760px;width:100%;border-collapse:collapse;font-size:14px\"><thead><tr style=\"background:#013366;color:#fff\"><th style=\"padding:10px;text-align:left\">\u00d6l\u00e7\u00fct<\/th><th style=\"padding:10px;text-align:left\">Clascoterone %5 (Breezula)<\/th><th style=\"padding:10px;text-align:left\">Finasterid 1 mg<\/th><th style=\"padding:10px;text-align:left\">Topikal Minoksidil<\/th><\/tr><\/thead><tbody>\n<tr style=\"border-bottom:1px solid #e3e8ef\"><td style=\"padding:10px\"><strong>Etki prensibi<\/strong><\/td><td style=\"padding:10px\">androjen resept\u00f6r\u00fc antagonisti (lokal)<\/td><td style=\"padding:10px\">5\u03b1-red\u00fcktaz inhibit\u00f6r\u00fc (sistemik, DHT&#8217;yi d\u00fc\u015f\u00fcr\u00fcr)<\/td><td style=\"padding:10px\">kan dola\u015f\u0131m\u0131 \/ anajen evre uzatma (hormon de\u011fil)<\/td><\/tr>\n<tr style=\"border-bottom:1px solid #e3e8ef;background:#f7fafd\"><td style=\"padding:10px\"><strong>Uygulama<\/strong><\/td><td style=\"padding:10px\">topikal (sa\u00e7l\u0131 deri \u00e7\u00f6zeltisi)<\/td><td style=\"padding:10px\">oral (tablet)<\/td><td style=\"padding:10px\">topikal (\u00e7\u00f6zelti\/k\u00f6p\u00fck)<\/td><\/tr>\n<tr style=\"border-bottom:1px solid #e3e8ef\"><td style=\"padding:10px\"><strong>Sistemik hormon etkisi<\/strong><\/td><td style=\"padding:10px\">\u00e7ok az ila yok<\/td><td style=\"padding:10px\">evet, kandaki DHT&#8217;yi yakla\u015f\u0131k %65 ila %70 d\u00fc\u015f\u00fcr\u00fcr<\/td><td style=\"padding:10px\">yok<\/td><\/tr>\n<tr style=\"border-bottom:1px solid #e3e8ef;background:#f7fafd\"><td style=\"padding:10px\"><strong>AGA&#8217;ya kar\u015f\u0131 ruhsat (DE\/AB)<\/strong><\/td><td style=\"padding:10px\"><strong>hay\u0131r (deneysel)<\/strong><\/td><td style=\"padding:10px\">evet (re\u00e7eteye tabi)<\/td><td style=\"padding:10px\">evet (re\u00e7etesiz)<\/td><\/tr>\n<tr style=\"border-bottom:1px solid #e3e8ef\"><td style=\"padding:10px\"><strong>Bilinen yan etkiler<\/strong><\/td><td style=\"padding:10px\">lokal cilt reaksiyonlar\u0131, yayg\u0131n kullan\u0131mda HPA bask\u0131lanmas\u0131 olas\u0131<\/td><td style=\"padding:10px\">cinsel i\u015flev bozukluklar\u0131, ruh hali de\u011fi\u015fiklikleri, post-finasterid sendromu (tart\u0131\u015fmal\u0131)<\/td><td style=\"padding:10px\">hipertrikoz, sa\u00e7l\u0131 deri tahri\u015fi<\/td><\/tr>\n<tr style=\"border-bottom:1px solid #e3e8ef;background:#f7fafd\"><td style=\"padding:10px\"><strong>Uzun d\u00f6nem verileri<\/strong><\/td><td style=\"padding:10px\">s\u0131n\u0131rl\u0131 (12 ay, hakem denetimi beklemede)<\/td><td style=\"padding:10px\">kapsaml\u0131 (25 y\u0131l\u0131 a\u015fk\u0131n)<\/td><td style=\"padding:10px\">kapsaml\u0131<\/td><\/tr>\n<tr style=\"border-bottom:1px solid #e3e8ef\"><td style=\"padding:10px\"><strong>Uygun evreler<\/strong><\/td><td style=\"padding:10px\">hafif ila orta (Norwood III ila V)<\/td><td style=\"padding:10px\">hafif ila orta<\/td><td style=\"padding:10px\">hafif ila orta<\/td><\/tr>\n<\/tbody><\/table>\n<p style=\"font-size:13px;color:#6b7280;margin:8px 0 0\">Nesnel bir kar\u015f\u0131la\u015ft\u0131rma, tedavi \u00f6nerisi de\u011fildir. Kaynaklar: gesund.bund.de; Mazzetti ve ark. 2019; DermNet NZ. Her tedaviden \u00f6nce bir hekimle g\u00f6r\u00fc\u015f\u00fcn.<\/p>\n<\/div>\n\n\n\n<p class=\"wp-block-paragraph\">Post-finasterid sendromuna gelince (kullan\u0131m\u0131n b\u0131rak\u0131lmas\u0131ndan sonra dahi s\u00fcren cinsel bozukluklar, ruh hali ve bili\u015fsel \u015fik\u00e2yetler): bilimsel olarak ba\u011f\u0131ms\u0131z bir sendrom olarak kesin bi\u00e7imde tan\u0131nmam\u0131\u015ft\u0131r, ancak etkilenenlerin \u00f6nemli bir k\u0131sm\u0131 taraf\u0131ndan bildirilmektedir. Clascoterone&#8217;un teorik \u00fcst\u00fcnl\u00fc\u011f\u00fc, kandaki DHT d\u00fczeyini hi\u00e7 d\u00fc\u015f\u00fcrmemesinde yatar.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Clascoterone&#8217;un Minoksidil ile kombinasyonu, farkl\u0131 etki mekanizmalar\u0131 nedeniyle teorik olarak mant\u0131kl\u0131 kabul ediliyor; ancak klinik kombinasyon \u00e7al\u0131\u015fmalar\u0131 \u015fimdiye dek eksik. Halihaz\u0131rda Minoksidil kullananlar, temel bilgileri <a href=\"https:\/\/elithair.com\/tr\/minoksidil-kullanmadan-once-bilmeniz-gerekenler\/\">sa\u00e7 d\u00f6k\u00fclmesine kar\u015f\u0131 Minoksidil<\/a> yaz\u0131m\u0131zda bulabilir.<\/p>\n\n\n\n<h2 id=\"h-clascoterone-veya-breezula-turkiye-de-satin-alinabilir-mi\" class=\"wp-block-heading\">Clascoterone veya Breezula T\u00fcrkiye&#8217;de sat\u0131n al\u0131nabilir mi?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Sa\u00e7 d\u00f6k\u00fclmesine kar\u015f\u0131 %5 Clascoterone \u00e7\u00f6zeltisi olan Breezula, sat\u0131n al\u0131namaz ve re\u00e7eteyle de edinilemez (Haziran 2026 durumu). FDA&#8217;ya yap\u0131lacak ruhsat ba\u015fvurusu, Cosmo&#8217;ya g\u00f6re 2027 ba\u015f\u0131 i\u00e7in planlan\u0131yor; m\u00fcmk\u00fcn olan en erken ABD ruhsat\u0131 2027&#8217;nin ortas\u0131 ila sonu, AB ruhsat\u0131 ise zaman olarak bunun ard\u0131ndan olacakt\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Akne kremi Winlevi (%1) Ekim 2025&#8217;ten beri AB&#8217;de bulunabiliyor; ancak yaln\u0131zca akneye kar\u015f\u0131, sa\u00e7 d\u00f6k\u00fclmesine kar\u015f\u0131 de\u011fil. Sa\u00e7l\u0131 deride endikasyon d\u0131\u015f\u0131 (off-label) kullan\u0131m, ger\u00e7ek\u00e7i a\u00e7\u0131dan uygun de\u011fildir: konsantrasyon %1 ile \u00e7ok d\u00fc\u015f\u00fckt\u00fcr (AGA i\u00e7in yakla\u015f\u0131k %5 ila %7,5 gerekir) ve krem ta\u015f\u0131y\u0131c\u0131s\u0131 y\u00fcz aknesi i\u00e7in form\u00fcle edilmi\u015ftir; sa\u00e7lar\u0131 yap\u0131\u015ft\u0131r\u0131r ve sa\u00e7l\u0131 derinin folik\u00fcllerine yeterince n\u00fcfuz etmez.<\/p>\n\n\n\n<div role=\"alert\" style=\"background:#fdeeee;border:2px solid #d64545;border-radius:10px;padding:16px 18px;margin:4px 0 24px\">\n<p style=\"margin:0 0 8px;display:flex;align-items:center;gap:8px;color:#b3261e;font-weight:700;font-size:16px\"><span aria-hidden=\"true\" style=\"display:inline-flex;align-items:center;justify-content:center;width:24px;height:24px;background:#d64545;color:#fff;border-radius:50%;font-size:15px;line-height:1\">&#9888;<\/span> Uyar\u0131: \u015e\u00fcpheli internet kaynaklar\u0131na ve kendi ba\u015f\u0131n\u0131za \u00fcretime dikkat<\/p>\n<p style=\"margin:0;color:#2e3033;font-size:15px;line-height:1.65\">Alibaba gibi platformlarda ham Clascoterone tozu (CB-03-01) sat\u0131\u015fa sunuluyor. Bu t\u00fcr \u00fcr\u00fcnler ne farmakolojik olarak denetlenmi\u015ftir ne de GMP&#8217;ye uygun \u00fcretilmi\u015ftir; safl\u0131k, konsantrasyon ve sterilite g\u00fcvence alt\u0131nda de\u011fildir. Kendi ba\u015f\u0131n\u0131za tent\u00fcr \u00fcretmek Almanya ve AB&#8217;de yasal de\u011fildir ve sa\u011fl\u0131k a\u00e7\u0131s\u0131ndan risklidir. Bundan uzak durun.<\/p>\n<\/div>\n\n\n\n<p class=\"wp-block-paragraph\">Maliyetlere ili\u015fkin resmi bir veri bulunmuyor. ABD pazar analistleri, geri \u00f6deme olmaks\u0131z\u0131n ayl\u0131k 90 ila 150 USD tahmininde bulunuyor. Almanya&#8217;da androjenetik alopesi geri \u00f6deme kapsam\u0131nda bir hastal\u0131k say\u0131lmaz; yasal sa\u011fl\u0131k sigortas\u0131 bu t\u00fcr tedavi masraflar\u0131n\u0131 genellikle kar\u015f\u0131lamaz (gesund.bund.de).<\/p>\n\n\n\n<h2 id=\"h-clascoterone-kimler-icin-uygundur-kimler-icin-degildir\" class=\"wp-block-heading\">Clascoterone kimler i\u00e7in uygundur, kimler i\u00e7in de\u011fildir?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">\u00c7al\u0131\u015fma verilerine g\u00f6re Clascoterone, hafif ila orta d\u00fczeyde androjenetik alopesisi olan erkekler, yani Norwood evre III (vertex) ila V i\u00e7in uygundur. H\u00e2l\u00e2 mevcut olan folik\u00fclleri stabilize edebilir, ancak halihaz\u0131rda \u00f6lm\u00fc\u015f folik\u00fclleri geri getirmez. T\u00fcm AGA ila\u00e7lar\u0131 gibi s\u00fcrekli tedavi gerektirir; kullan\u0131m b\u0131rak\u0131ld\u0131\u011f\u0131nda etki kaybolur.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pratikte bu \u015fu anlama gelir: Breezula, ruhsatland\u0131r\u0131lmas\u0131 halinde, etkilenen b\u00f6lgedeki kuru sa\u00e7l\u0131 deriye g\u00fcnde iki kez uygulanan bir \u00e7\u00f6zelti olurdu; a\u015fa\u011f\u0131 yukar\u0131 Minoksidil kullan\u0131m\u0131na benzer. Bir k\u00fcr de\u011fil, y\u0131llar s\u00fcren bir s\u00fcrekli tedavidir. 12 ayl\u0131k verilerde, 6 ay\u0131n ard\u0131ndan vehik\u00fcle ge\u00e7en erkekler, daha \u00f6nce elde ettikleri kazan\u0131mlar\u0131 yeniden kaybetti (Cosmo, Nisan 2026).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Etken madde, art\u0131k canl\u0131 folik\u00fcl\u00fcn kalmad\u0131\u011f\u0131 ilerlemi\u015f AGA&#8217;da (Norwood VI ila VII) ve ayr\u0131ca gebeler, emziren ki\u015filer ve \u00e7ocuklarda uygun de\u011fildir. Belirleyici olan ba\u015fka bir ayr\u0131md\u0131r: diff\u00fcz sa\u00e7 d\u00f6k\u00fclmesi antiandrojenlere yan\u0131t vermez.<\/p>\n\n\n\n<h3 id=\"h-once-nedeni-netlestirin-aga-mi-yoksa-diffuz-sac-dokulmesi-mi\" class=\"wp-block-heading\">\u00d6nce nedeni netle\u015ftirin: AGA m\u0131, yoksa diff\u00fcz sa\u00e7 d\u00f6k\u00fclmesi mi?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Clascoterone gibi antiandrojenler yaln\u0131zca androjenetik alopesinin hormonal-genetik nedenini hedefler. Diff\u00fcz sa\u00e7 d\u00f6k\u00fclmesinin (telojen effluvium) ba\u015fka tetikleyicileri vard\u0131r; \u00f6rne\u011fin demir eksikli\u011fi (ferritin s\u0131kl\u0131kla 30 ila 70 \u00b5g\/l alt\u0131nda), tiroid bozukluklar\u0131, stres veya yetersiz beslenme. Burada bir antiandrojen i\u015fe yaramaz; \u00f6nce neden ara\u015ft\u0131r\u0131lmal\u0131d\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Bu nedenle her ila\u00e7 tedavisinden \u00f6nce trikoskopi ve gerekirse kan tahliliyle hekim tan\u0131s\u0131 gelir. AGA m\u0131 yoksa ba\u015fka bir bi\u00e7im mi s\u00f6z konusu oldu\u011fu, sa\u00e7l\u0131 derinin ve sa\u00e7 d\u00f6k\u00fclmesi deseninin g\u00f6rsel bir desen analiziyle de\u011ferlendirilebilir. Ancak b\u00f6yle bir sa\u00e7 analizi, \u00f6rne\u011fin demir veya tiroid de\u011ferlerinin ara\u015ft\u0131r\u0131lmas\u0131 i\u00e7in yap\u0131lan bir hekim kan testinin yerini tutmaz; konuya dair daha fazlas\u0131 sa\u00e7 d\u00f6k\u00fclmesinde kan testi yaz\u0131m\u0131zda.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large is-resized\" style=\"max-width:720px;margin-left:auto;margin-right:auto\"><img loading=\"lazy\" decoding=\"async\" width=\"1536\" height=\"1024\" src=\"https:\/\/elithair.com\/tr\/wp-content\/uploads\/sites\/10\/2026\/06\/mann_spiegel.png\" alt=\"Mann betrachtet seinen lichter werdenden Haaransatz im Spiegel\" class=\"wp-image-83215\" style=\"width:720px;max-width:100%;height:auto\" srcset=\"https:\/\/elithair.com\/tr\/wp-content\/uploads\/sites\/10\/2026\/06\/mann_spiegel.png 1536w, https:\/\/elithair.com\/tr\/wp-content\/uploads\/sites\/10\/2026\/06\/mann_spiegel-300x200.png 300w, https:\/\/elithair.com\/tr\/wp-content\/uploads\/sites\/10\/2026\/06\/mann_spiegel-1024x683.png 1024w, https:\/\/elithair.com\/tr\/wp-content\/uploads\/sites\/10\/2026\/06\/mann_spiegel-768x512.png 768w\" sizes=\"(max-width: 767px) 100vw, 660px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\">Neden ancak netle\u015fti\u011finde, bir tedaviye anlaml\u0131 bi\u00e7imde karar verilebilir. \u0130\u015fte tam burada bir\u00e7ok ki\u015fi i\u00e7in pratik soru ortaya \u00e7\u0131k\u0131yor: Clascoterone hen\u00fcz mevcut de\u011fil; Breezula belki gelene dek ne yapmal\u0131?<\/p>\n\n\n\n<h2 id=\"h-breezula-yi-beklerken-etkilenenler-2028-e-kadar-ne-yapabilir\" class=\"wp-block-heading\">Breezula&#8217;y\u0131 beklerken: Etkilenenler 2028&#8217;e kadar ne yapabilir?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Breezula&#8217;n\u0131n ger\u00e7ek\u00e7i olarak 2028 ya da daha sonra T\u00fcrkiye&#8217;de bulunabilir hale gelmesine kadar, etkilenenlerin eli kolu ba\u011fl\u0131 beklemesi gerekmez. Tam aksine: kal\u0131tsal sa\u00e7 d\u00f6k\u00fclmesinde erken hareket etmek \u00f6nemlidir, \u00e7\u00fcnk\u00fc bir kez \u00f6lm\u00fc\u015f folik\u00fclleri hi\u00e7bir ila\u00e7 geri getiremez. Mevcut sa\u00e7 varl\u0131\u011f\u0131n\u0131 \u015fimdiden stabilize etmek i\u00e7in yerle\u015fik, ruhsatl\u0131 se\u00e7enekler vard\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">An\u0131nda stabilizasyon i\u00e7in bug\u00fcn \u00fc\u00e7 yol iyi kan\u0131tlanm\u0131\u015ft\u0131r: <a href=\"https:\/\/elithair.com\/tr\/minoksidil-kullanmadan-once-bilmeniz-gerekenler\/\">Minoksidil<\/a> (re\u00e7etesiz, topikal, b\u00fcy\u00fcme evresini uzat\u0131r), Finasterid (re\u00e7eteye tabi, DHT d\u00fczeyini d\u00fc\u015f\u00fcr\u00fcr) ve tamamlay\u0131c\u0131 olarak kendi kan\u0131yla yap\u0131lan PRP tedavisi. Hekim a\u00e7\u0131s\u0131ndan hangi se\u00e7ene\u011fin uygun oldu\u011fu evreye, tolere edilebilirli\u011fe ve ki\u015fisel tercihlere ba\u011fl\u0131d\u0131r ve bir hekimin elinde olmal\u0131d\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Buna kar\u015f\u0131n tek tek b\u00f6lgeler, folik\u00fcllerin orada kal\u0131c\u0131 olarak kaybolmas\u0131 nedeniyle \u00e7oktan dazlakla\u015ft\u0131ysa, hi\u00e7bir topikal madde bunlar\u0131 yenileyemez. O zaman <a href=\"https:\/\/elithair.com\/tr\/\">sa\u00e7 ekimi<\/a> (FUE veya DHI) t\u0131bbi a\u00e7\u0131dan yerle\u015fik yoldur, \u00e7\u00fcnk\u00fc ensedeki kendi DHT&#8217;ye diren\u00e7li folik\u00fclleri seyrelmi\u015f b\u00f6lgelere ta\u015f\u0131r. Clascoterone gibi bir etken madde, gelecekte kalan kendi sa\u00e7 varl\u0131\u011f\u0131n\u0131 tamamlay\u0131c\u0131 bi\u00e7imde stabilize edebilir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Bu nedenle anlaml\u0131 ilk ad\u0131m, kendi sa\u00e7 d\u00f6k\u00fclmesi tipinizi ve evrenizi de\u011ferlendirtmektir. Elithair&#8217;in \u00fccretsiz sa\u00e7 analizi, foto\u011fraflar\u0131n\u0131z\u0131n g\u00f6rsel bir desen analizidir; kal\u0131tsal bir desenin s\u00f6z konusu olup olmad\u0131\u011f\u0131n\u0131 ve hangi yollar\u0131n ger\u00e7ek\u00e7i oldu\u011funu ba\u011flay\u0131c\u0131 olmadan g\u00f6sterir. Bir hekim kan testinin yerini tutmaz, ancak ileri planlama i\u00e7in iyi bir ba\u015flang\u0131\u00e7 noktas\u0131d\u0131r.<\/p>\n\n\n\n<div class=\"wp-block-buttons has-custom-css is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-fe48e5de wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-white-color has-text-color has-background has-link-color wp-element-button\" href=\"https:\/\/elithair.com\/tr\/sac-analizi\/\" style=\"border-top-left-radius:30px;border-top-right-radius:30px;border-bottom-left-radius:30px;border-bottom-right-radius:30px;background-color:#0079f1\">\u00dccretsiz sa\u00e7 analizini ba\u015flat\u0131n<\/a><\/div>\n<\/div>\n\n\n\n<h2 id=\"h-gelisim-ve-ruhsatlandirma-zaman-cizelgesi\" class=\"wp-block-heading\">Geli\u015fim ve ruhsatland\u0131rma zaman \u00e7izelgesi<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Clascoterone&#8217;un geli\u015fimi, akne ruhsat\u0131ndan tamamlanm\u0131\u015f sa\u00e7 d\u00f6k\u00fclmesi \u00e7al\u0131\u015fmalar\u0131na uzan\u0131r. Breezula ruhsatland\u0131r\u0131l\u0131rsa, Cosmo&#8217;ya g\u00f6re Minoksidil (1988) ve Finasterid&#8217;den (1997) bu yana, yani 30 y\u0131l\u0131 a\u015fk\u0131n s\u00fcrenin ard\u0131ndan yeni bir etki mekanizmas\u0131na sahip ilk topikal AGA ilac\u0131 olurdu.<\/p>\n\n\n\n<div style=\"overflow-x:auto;margin-bottom:28px\"><table class=\"htk-table\" style=\"min-width:560px;width:100%;border-collapse:collapse;font-size:15px\"><thead><tr style=\"background:#013366;color:#fff\"><th style=\"padding:11px;text-align:left\">Tarih<\/th><th style=\"padding:11px;text-align:left\">Kilometre ta\u015f\u0131<\/th><\/tr><\/thead><tbody>\n<tr style=\"border-bottom:1px solid #e3e8ef\"><td style=\"padding:11px\">A\u011fustos 2020<\/td><td style=\"padding:11px\">Winlevi&#8217;nin (%1) akneye kar\u015f\u0131 FDA ruhsat\u0131<\/td><\/tr>\n<tr style=\"border-bottom:1px solid #e3e8ef;background:#f7fafd\"><td style=\"padding:11px\">Ekim 2025<\/td><td style=\"padding:11px\">Winlevi&#8217;nin AB&#8217;de EMA ruhsat\u0131 (ek izleme alt\u0131nda)<\/td><\/tr>\n<tr style=\"border-bottom:1px solid #e3e8ef\"><td style=\"padding:11px\">Aral\u0131k 2025<\/td><td style=\"padding:11px\">Breezula Faz III topline sonu\u00e7lar\u0131 (SCALP 1 ve SCALP 2)<\/td><\/tr>\n<tr style=\"border-bottom:1px solid #e3e8ef;background:#f7fafd\"><td style=\"padding:11px\">Nisan 2026<\/td><td style=\"padding:11px\">Faz III 12 ayl\u0131k g\u00fcvenlik verileri<\/td><\/tr>\n<tr style=\"border-bottom:1px solid #e3e8ef\"><td style=\"padding:11px\">2027 ba\u015f\u0131 (planlanan)<\/td><td style=\"padding:11px\">Breezula i\u00e7in FDA ruhsat ba\u015fvurusu (NDA)<\/td><\/tr>\n<tr style=\"border-bottom:1px solid #e3e8ef;background:#f7fafd\"><td style=\"padding:11px\">2028 veya sonras\u0131 (beklenen)<\/td><td style=\"padding:11px\">FDA&#8217;n\u0131n ard\u0131ndan olas\u0131 AB ruhsat\u0131<\/td><\/tr>\n<\/tbody><\/table>\n<p style=\"font-size:13px;color:#6b7280;margin:8px 0 0\">Takvim garanti edilmez. Kaynaklar: FDA; EMA Winlevi-EPAR; Cosmo Pharmaceuticals; GenEngNews.<\/p>\n<\/div>\n\n\n\n<h2 id=\"h-sonuc-clascoterone-2026-arastirma-durumu\" class=\"wp-block-heading\">Sonu\u00e7: Clascoterone, 2026 ara\u015ft\u0131rma durumu<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Clascoterone, Breezula ad\u0131yla, geni\u015f kapsaml\u0131 bir Faz III \u00e7al\u0131\u015fmas\u0131nda androjenetik alopesiye kar\u015f\u0131 istatistiksel olarak anlaml\u0131 sonu\u00e7lar g\u00f6steren \u015fimdiye dek tek topikal androjen resept\u00f6r\u00fc antagonistidir. Bu ger\u00e7ek bir ilerlemedir, \u00e7\u00fcnk\u00fc 30 y\u0131l\u0131 a\u015fk\u0131n s\u00fcredir yeni bir etki mekanizmas\u0131na sahip topikal bir AGA ilac\u0131 eklenmemi\u015fti.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ayn\u0131 zamanda temkinli olmak yerinde: Faz III birincil verileri hen\u00fcz hakem denetiminden ge\u00e7mi\u015f bi\u00e7imde yay\u0131mlanmad\u0131; y\u0131llar boyu uzun d\u00f6nem g\u00fcvenli\u011fi ve nihai mutlak k\u0131l say\u0131lar\u0131 beklemede. T\u00fcrkiye&#8217;de bir ruhsata kadar sab\u0131r gerekiyor, ger\u00e7ek\u00e7i olarak 2028 veya sonras\u0131. Endikasyon d\u0131\u015f\u0131 kullan\u0131mdan, kendi ba\u015f\u0131na \u00fcretimden ve denetimsiz internet kaynaklar\u0131ndan temin etmekten a\u00e7\u0131k\u00e7a ka\u00e7\u0131n\u0131lmal\u0131d\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Bug\u00fcn g\u00f6r\u00fcn\u00fcr sa\u00e7 kayb\u0131ndan muzdarip olan ki\u015fi, \u00f6nce nedeni hekime ara\u015ft\u0131rtmal\u0131d\u0131r. Folik\u00fcllerin kal\u0131c\u0131 olarak kaybedildi\u011fi genetik kaynakl\u0131 sa\u00e7 d\u00f6k\u00fclmesinde, sa\u00e7 ekimi yerle\u015fik, planlanabilir se\u00e7enek olmay\u0131 s\u00fcrd\u00fcr\u00fcr; Clascoterone gibi etken maddeler ise gelecekte mevcut sa\u00e7 varl\u0131\u011f\u0131n\u0131 tamamlay\u0131c\u0131 bi\u00e7imde stabilize edebilir.<\/p>\n\n\n\n<h2 id=\"h-clascoterone-hakkinda-sik-sorulan-sorular\" class=\"wp-block-heading\">Clascoterone hakk\u0131nda s\u0131k sorulan sorular<\/h2>\n\n\n\n<div>\n<div style=\"border:1px solid #e3e8ef;border-radius:10px;padding:16px;margin-bottom:12px\">\n<p style=\"margin:0 0 6px;color:#013366;font-weight:600;font-size:16px\">Winlevi ile Breezula aras\u0131ndaki fark nedir?<\/p>\n<p style=\"margin:0;color:#2e3033;font-size:15px;line-height:1.6\">Ayn\u0131 etken madde (Clascoterone), farkl\u0131 form\u00fclasyon ve g\u00fc\u00e7. Winlevi, akneye kar\u015f\u0131 %1&#8217;lik bir kremdir ve AB\/ABD&#8217;de ruhsatl\u0131d\u0131r. Breezula ise kal\u0131tsal sa\u00e7 d\u00f6k\u00fclmesine kar\u015f\u0131 %5&#8217;lik bir \u00e7\u00f6zeltidir, h\u00e2l\u00e2 ara\u015ft\u0131rma a\u015famas\u0131ndad\u0131r ve ruhsatl\u0131 de\u011fildir (Haziran 2026 durumu).<\/p>\n<\/div>\n<div style=\"border:1px solid #e3e8ef;border-radius:10px;padding:16px;margin-bottom:12px\">\n<p style=\"margin:0 0 6px;color:#013366;font-weight:600;font-size:16px\">Clascoterone bir DHT blokeri midir?<\/p>\n<p style=\"margin:0;color:#2e3033;font-size:15px;line-height:1.6\">Klasik anlamda de\u011fil. Clascoterone, DHT \u00fcretimini bloke etmez; bunu Finasterid yapar. Bunun yerine DHT&#8217;nin ba\u011fland\u0131\u011f\u0131 androjen resept\u00f6r\u00fcn\u00fc bloke eder. Kandaki DHT d\u00fczeyi bu s\u0131rada de\u011fi\u015fmeden kal\u0131r. Yani folik\u00fclde bir resept\u00f6r blokeridir, bir \u00fcretim inhibit\u00f6r\u00fc de\u011fildir.<\/p>\n<\/div>\n<div style=\"border:1px solid #e3e8ef;border-radius:10px;padding:16px;margin-bottom:12px\">\n<p style=\"margin:0 0 6px;color:#013366;font-weight:600;font-size:16px\">Winlevi&#8217;yi sa\u00e7lar\u0131m i\u00e7in endikasyon d\u0131\u015f\u0131 kullanabilir miyim?<\/p>\n<p style=\"margin:0;color:#2e3033;font-size:15px;line-height:1.6\">Hay\u0131r. Winlevi, AGA i\u00e7in gereken yakla\u015f\u0131k %5 yerine yaln\u0131zca %1 Clascoterone i\u00e7erir. Krem, sa\u00e7l\u0131 deriye n\u00fcfuz i\u00e7in de\u011fil, y\u00fcz aknesi i\u00e7in form\u00fcle edilmi\u015ftir; sa\u00e7lar\u0131 yap\u0131\u015ft\u0131r\u0131r ve folik\u00fcllere yeterince ula\u015fmaz. Endikasyon d\u0131\u015f\u0131 kullan\u0131m ne etkilidir ne de \u00f6nerilir.<\/p>\n<\/div>\n<div style=\"border:1px solid #e3e8ef;border-radius:10px;padding:16px;margin-bottom:12px\">\n<p style=\"margin:0 0 6px;color:#013366;font-weight:600;font-size:16px\">Clascoterone, Finasterid&#8217;den daha m\u0131 iyidir?<\/p>\n<p style=\"margin:0;color:#2e3033;font-size:15px;line-height:1.6\">\u00c7al\u0131\u015fmalardan do\u011frudan bir kafa kafaya kar\u015f\u0131la\u015ft\u0131rma bulunmuyor. Clascoterone, sistemik bir DHT m\u00fcdahalesi olmaks\u0131z\u0131n resept\u00f6rde lokal etki g\u00f6sterir; Finasterid sistemik etki g\u00f6sterir ve 25 y\u0131l\u0131 a\u015fk\u0131n s\u00fcredir kapsaml\u0131 bi\u00e7imde kan\u0131tlanm\u0131\u015ft\u0131r. \u0130kisi de AGA&#8217;y\u0131 stabilize eder, kaybolmu\u015f folik\u00fclleri geri getirmeden.<\/p>\n<\/div>\n<div style=\"border:1px solid #e3e8ef;border-radius:10px;padding:16px;margin-bottom:12px\">\n<p style=\"margin:0 0 6px;color:#013366;font-weight:600;font-size:16px\">Breezula T\u00fcrkiye&#8217;de ne zaman piyasaya \u00e7\u0131kacak?<\/p>\n<p style=\"margin:0;color:#2e3033;font-size:15px;line-height:1.6\">En erken 2028, FDA ruhsat\u0131n\u0131n (ba\u015fvuru 2027 ba\u015f\u0131 i\u00e7in planland\u0131) ba\u015far\u0131yla sonu\u00e7lanmas\u0131 ve EMA&#8217;n\u0131n ard\u0131ndan de\u011ferlendirmesini tamamlamas\u0131 ko\u015fuluyla. Ba\u011flay\u0131c\u0131 bir ruhsat taahh\u00fct edilmemi\u015ftir (Haziran 2026 durumu).<\/p>\n<\/div>\n<div style=\"border:1px solid #e3e8ef;border-radius:10px;padding:16px;margin-bottom:12px\">\n<p style=\"margin:0 0 6px;color:#013366;font-weight:600;font-size:16px\">Clascoterone, Minoksidil ile kombine edilebilir mi?<\/p>\n<p style=\"margin:0;color:#2e3033;font-size:15px;line-height:1.6\">Etki mekanizmalar\u0131 farkl\u0131 oldu\u011fundan ve bilinen bir antagonizm bulunmad\u0131\u011f\u0131ndan teorik olarak mant\u0131kl\u0131d\u0131r. Ancak klinik kombinasyon \u00e7al\u0131\u015fmalar\u0131 \u015fimdiye dek eksiktir. Bir uygulama yaln\u0131zca hekim dan\u0131\u015fmanl\u0131\u011f\u0131ndan sonra yap\u0131lmal\u0131d\u0131r.<\/p>\n<\/div>\n<div style=\"border:1px solid #e3e8ef;border-radius:10px;padding:16px;margin-bottom:12px\">\n<p style=\"margin:0 0 6px;color:#013366;font-weight:600;font-size:16px\">Clascoterone diff\u00fcz sa\u00e7 d\u00f6k\u00fclmesinde de yard\u0131mc\u0131 olur mu?<\/p>\n<p style=\"margin:0;color:#2e3033;font-size:15px;line-height:1.6\">Hay\u0131r. Diff\u00fcz sa\u00e7 d\u00f6k\u00fclmesinin genellikle demir eksikli\u011fi, tiroid bozukluklar\u0131 veya stres gibi ba\u015fka nedenleri vard\u0131r. Antiandrojenler yaln\u0131zca AGA&#8217;n\u0131n hormonal-genetik nedenini hedefler. Diff\u00fcz sa\u00e7 d\u00f6k\u00fclmesinde \u00f6nce neden hekime ara\u015ft\u0131rt\u0131lmal\u0131d\u0131r.<\/p>\n<\/div>\n<div style=\"border:1px solid #e3e8ef;border-radius:10px;padding:16px;margin-bottom:0\">\n<p style=\"margin:0 0 6px;color:#013366;font-weight:600;font-size:16px\">Clascoterone kad\u0131nlarda etki eder mi?<\/p>\n<p style=\"margin:0;color:#2e3033;font-size:15px;line-height:1.6\">Yaln\u0131zca ilk, yetersiz ipu\u00e7lar\u0131 var. 293 kad\u0131nla yap\u0131lan bir Faz II \u00e7al\u0131\u015fmas\u0131nda yaln\u0131zca %5 Clascoterone kullanan 30 ya\u015f alt\u0131 alt grup anlaml\u0131 bir etki g\u00f6sterdi (p = 0,0391). Kad\u0131nlar geneli i\u00e7in veri durumu yeterli de\u011fildir; kad\u0131nlara y\u00f6nelik bir Faz III program\u0131 y\u00fcr\u00fct\u00fclmemektedir.<\/p>\n<\/div>\n<\/div>\n\n\n\n<h2 id=\"h-kaynaklar\" class=\"wp-block-heading\">Kaynaklar<\/h2>\n\n\n\n<div style=\"background:#f7fafd;border:1px solid #e3e8ef;border-radius:10px;padding:18px 20px;margin-bottom:18px\">\n<ul style=\"margin:0;padding-left:20px;color:#2e3033;font-size:14px;line-height:1.75\">\n<li>Rosette C. et al. (2019): Cortexolone 17\u03b1-Propionate (Clascoterone) is an Androgen Receptor Antagonist in Dermal Papilla Cells In Vitro. Journal of Drugs in Dermatology. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30811143\/\" target=\"_blank\" rel=\"noopener\">PubMed 30811143<\/a><\/li>\n<li>Mazzetti A. et al. (2019): Pharmacokinetic Profile, Safety, and Tolerability of Clascoterone (CB-03-01) Topical Cream, 1%. Journal of Drugs in Dermatology. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31251549\/\" target=\"_blank\" rel=\"noopener\">PubMed 31251549<\/a><\/li>\n<li>FDA \/ DailyMed: Winlevi (Clascoterone) Prescribing Information, Initial U.S. Approval 2020. <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=1673a84b-7f5c-47ab-a99c-1e3db21a6a09\" target=\"_blank\" rel=\"noopener\">DailyMed Winlevi<\/a><\/li>\n<li>EMA: Winlevi (Clascoterone) EPAR, ruhsat 17 Ekim 2025. <a href=\"https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/winlevi\" target=\"_blank\" rel=\"noopener\">European Medicines Agency<\/a><\/li>\n<li>Cosmo Pharmaceuticals: Faz III topline sonu\u00e7lar\u0131 SCALP 1 ve SCALP 2, Aral\u0131k 2025. <a href=\"https:\/\/www.cosmohealthconfidence.com\/news\/11029858-breezula-phase-iii-results\" target=\"_blank\" rel=\"noopener\">cosmohealthconfidence.com<\/a><\/li>\n<li>Cosmo Pharmaceuticals: Faz III 12 ayl\u0131k g\u00fcvenlik verileri, Nisan 2026. <a href=\"https:\/\/www.cosmohealthconfidence.com\/news\/98958067-clascoterone-12-month-safety-results-ende\" target=\"_blank\" rel=\"noopener\">cosmohealthconfidence.com<\/a><\/li>\n<li>Cassiopea S.p.A.: Erkeklerde Faz II 12 ayl\u0131k sonu\u00e7lar\u0131, Nisan 2019. <a href=\"https:\/\/www.finanznachrichten.de\/nachrichten-2019-04\/46472255-cassiopea-s-p-a-cassiopea-gibt-sehr-positive-phase-ii-zwoelfmonats-resultate-fuer-breezula-clascoterone-in-der-behandlung-von-androgenetischer-allop-353.htm\" target=\"_blank\" rel=\"noopener\">Finanznachrichten.de<\/a><\/li>\n<li>DermNet NZ: Clascoterone (yan etkiler, kontrendikasyonlar, d\u00fczenleme). <a href=\"https:\/\/dermnetnz.org\/topics\/clascoterone\" target=\"_blank\" rel=\"noopener\">DermNet NZ<\/a><\/li>\n<li>gesund.bund.de (BMG): Erkeklerde anlagebedingter (kal\u0131tsal) sa\u00e7 d\u00f6k\u00fclmesi. <a href=\"https:\/\/gesund.bund.de\/en\/anlagebedingter-haarausfall-beim-mann\" target=\"_blank\" rel=\"noopener\">gesund.bund.de<\/a><\/li>\n<\/ul>\n<\/div>\n\n\n\n<p style=\"font-size:13px;color:#6b7280;font-style:italic;margin-bottom:20px\">T\u0131bbi olarak g\u00f6zden ge\u00e7irilmi\u015ftir, durum Haziran 2026. Bu rehber bilgilendirme ama\u00e7l\u0131d\u0131r ve t\u0131bbi dan\u0131\u015fmanl\u0131\u011f\u0131n, tan\u0131n\u0131n veya tedavinin yerini tutmaz. Clascoterone (Breezula) sa\u00e7 d\u00f6k\u00fclmesine kar\u015f\u0131 ruhsatl\u0131 de\u011fildir. Hekiminize dan\u0131\u015fmadan tedavi karar\u0131 vermeyin.<\/p>\n\n\n\n<script type=\"application\/ld+json\">\n{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[\n{\"@type\":\"Question\",\"name\":\"Winlevi ile Breezula aras\u0131ndaki fark nedir?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Ayn\u0131 etken madde (Clascoterone), farkl\u0131 form\u00fclasyon ve g\u00fc\u00e7. Winlevi, akneye kar\u015f\u0131 %1'lik bir kremdir ve AB\/ABD'de ruhsatl\u0131d\u0131r. Breezula ise kal\u0131tsal sa\u00e7 d\u00f6k\u00fclmesine kar\u015f\u0131 %5'lik bir \u00e7\u00f6zeltidir, h\u00e2l\u00e2 ara\u015ft\u0131rma a\u015famas\u0131ndad\u0131r ve ruhsatl\u0131 de\u011fildir (Haziran 2026 durumu).\"}},\n{\"@type\":\"Question\",\"name\":\"Clascoterone bir DHT blokeri midir?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Klasik anlamda de\u011fil. Clascoterone, DHT \u00fcretimini bloke etmez; bunu Finasterid yapar. Bunun yerine DHT'nin ba\u011fland\u0131\u011f\u0131 androjen resept\u00f6r\u00fcn\u00fc bloke eder. Kandaki DHT d\u00fczeyi bu s\u0131rada de\u011fi\u015fmeden kal\u0131r. Yani folik\u00fclde bir resept\u00f6r blokeridir, bir \u00fcretim inhibit\u00f6r\u00fc de\u011fildir.\"}},\n{\"@type\":\"Question\",\"name\":\"Winlevi'yi sa\u00e7lar\u0131m i\u00e7in endikasyon d\u0131\u015f\u0131 kullanabilir miyim?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Hay\u0131r. Winlevi, AGA i\u00e7in gereken yakla\u015f\u0131k %5 yerine yaln\u0131zca %1 Clascoterone i\u00e7erir. Krem, sa\u00e7l\u0131 deriye n\u00fcfuz i\u00e7in de\u011fil, y\u00fcz aknesi i\u00e7in form\u00fcle edilmi\u015ftir; sa\u00e7lar\u0131 yap\u0131\u015ft\u0131r\u0131r ve folik\u00fcllere yeterince ula\u015fmaz. Endikasyon d\u0131\u015f\u0131 kullan\u0131m ne etkilidir ne de \u00f6nerilir.\"}},\n{\"@type\":\"Question\",\"name\":\"Clascoterone, Finasterid'den daha m\u0131 iyidir?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"\u00c7al\u0131\u015fmalardan do\u011frudan bir kafa kafaya kar\u015f\u0131la\u015ft\u0131rma bulunmuyor. Clascoterone, sistemik bir DHT m\u00fcdahalesi olmaks\u0131z\u0131n resept\u00f6rde lokal etki g\u00f6sterir; Finasterid sistemik etki g\u00f6sterir ve 25 y\u0131l\u0131 a\u015fk\u0131n s\u00fcredir kapsaml\u0131 bi\u00e7imde kan\u0131tlanm\u0131\u015ft\u0131r. \u0130kisi de AGA'y\u0131 stabilize eder, kaybolmu\u015f folik\u00fclleri geri getirmeden.\"}},\n{\"@type\":\"Question\",\"name\":\"Breezula T\u00fcrkiye'de ne zaman piyasaya \u00e7\u0131kacak?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"En erken 2028, FDA ruhsat\u0131n\u0131n (ba\u015fvuru 2027 ba\u015f\u0131 i\u00e7in planland\u0131) ba\u015far\u0131yla sonu\u00e7lanmas\u0131 ve EMA'n\u0131n ard\u0131ndan de\u011ferlendirmesini tamamlamas\u0131 ko\u015fuluyla. Ba\u011flay\u0131c\u0131 bir ruhsat taahh\u00fct edilmemi\u015ftir (Haziran 2026 durumu).\"}},\n{\"@type\":\"Question\",\"name\":\"Clascoterone, Minoksidil ile kombine edilebilir mi?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Etki mekanizmalar\u0131 farkl\u0131 oldu\u011fundan ve bilinen bir antagonizm bulunmad\u0131\u011f\u0131ndan teorik olarak mant\u0131kl\u0131d\u0131r. Ancak klinik kombinasyon \u00e7al\u0131\u015fmalar\u0131 \u015fimdiye dek eksiktir. Bir uygulama yaln\u0131zca hekim dan\u0131\u015fmanl\u0131\u011f\u0131ndan sonra yap\u0131lmal\u0131d\u0131r.\"}},\n{\"@type\":\"Question\",\"name\":\"Clascoterone diff\u00fcz sa\u00e7 d\u00f6k\u00fclmesinde de yard\u0131mc\u0131 olur mu?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Hay\u0131r. Diff\u00fcz sa\u00e7 d\u00f6k\u00fclmesinin genellikle demir eksikli\u011fi, tiroid bozukluklar\u0131 veya stres gibi ba\u015fka nedenleri vard\u0131r. Antiandrojenler yaln\u0131zca AGA'n\u0131n hormonal-genetik nedenini hedefler. Diff\u00fcz sa\u00e7 d\u00f6k\u00fclmesinde \u00f6nce neden hekime ara\u015ft\u0131rt\u0131lmal\u0131d\u0131r.\"}},\n{\"@type\":\"Question\",\"name\":\"Clascoterone kad\u0131nlarda etki eder mi?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yaln\u0131zca ilk, yetersiz ipu\u00e7lar\u0131 var. 293 kad\u0131nla yap\u0131lan bir Faz II \u00e7al\u0131\u015fmas\u0131nda yaln\u0131zca %5 Clascoterone kullanan 30 ya\u015f alt\u0131 alt grup anlaml\u0131 bir etki g\u00f6sterdi (p = 0,0391). Kad\u0131nlar geneli i\u00e7in veri durumu yeterli de\u011fildir; kad\u0131nlara y\u00f6nelik bir Faz III program\u0131 y\u00fcr\u00fct\u00fclmemektedir.\"}}\n]}\n<\/script>\n","protected":false},"excerpt":{"rendered":"<p>K\u0131sa yan\u0131t Sa\u00e7 d\u00f6k\u00fclmesi etkin maddesi Clascoterone (Cortexolone-17&alpha;-propionat), sa\u00e7 folik\u00fcl\u00fcndeki androjen resept\u00f6r\u00fcn\u00fc do\u011frudan bloke eden topikal bir antiandrojendir. Winlevi (%1) ad\u0131yla bir akne kremi olarak ruhsatl\u0131d\u0131r (FDA 2020, EMA Ekim 2025). Kal\u0131tsal sa\u00e7 d\u00f6k\u00fclmesine kar\u015f\u0131 ise Breezula (%5 \u00e7\u00f6zelti) olarak ara\u015ft\u0131r\u0131lmaktad\u0131r. Haziran 2026 itibar\u0131yla Breezula Almanya ve AB&#8217;de ne bulunmakta ne de re\u00e7ete edilebilmektedir. Etken [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":83216,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_yoast_wpseo_meta-robots-noindex":"2","_yoast_wpseo_meta-robots-nofollow":"","_yoast_wpseo_meta-robots-adv":"","_yoast_wpseo_canonical":"https:\/\/elithair.com\/tr\/clascoterone-sac-dokulmesi\/","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_twitter-title":"","_yoast_wpseo_twitter-description":"","_yoast_wpseo_twitter-image":"","_hm_hreflang_map":{"de":99367,"en":96879,"es":91811,"fr":97662,"it":107597,"pt":89657,"tr":83217,"uk":93868,"x_default":96678},"_hm_language_code":"tr","footnotes":""},"categories":[3],"tags":[],"class_list":["post-83217","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sac-ekimi-blog"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.3 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Sa\u00e7 d\u00f6k\u00fclmesi ilac\u0131 Clascoterone (Breezula): Etkisi, yan etkileri, \u00e7al\u0131\u015fmalar ve bulunabilirlik | Elithair<\/title>\n<meta name=\"description\" content=\"Sa\u00e7 d\u00f6k\u00fclmesi ilac\u0131 Clascoterone (Breezula): etkisi, yan etkileri, Faz III \u00e7al\u0131\u015fmalar\u0131, Finasterid ile kar\u015f\u0131la\u015ft\u0131rmas\u0131 ve T\u00fcrkiye&#039;de bulunup bulunmad\u0131\u011f\u0131.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/elithair.com\/tr\/clascoterone-sac-dokulmesi\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sa\u00e7 d\u00f6k\u00fclmesi ilac\u0131 Clascoterone: Etkisi, \u00e7al\u0131\u015fmalar ve 2026 durumu\" \/>\n<meta property=\"og:description\" content=\"Sa\u00e7 d\u00f6k\u00fclmesi ilac\u0131 Clascoterone (Breezula): etkisi, yan etkileri, Faz III \u00e7al\u0131\u015fmalar\u0131, Finasterid ile kar\u015f\u0131la\u015ft\u0131rmas\u0131 ve T\u00fcrkiye&#039;de bulunup bulunmad\u0131\u011f\u0131.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/elithair.com\/tr\/clascoterone-sac-dokulmesi\/\" \/>\n<meta property=\"og:site_name\" content=\"Elithair\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-24T12:38:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/elithair.com\/tr\/wp-content\/uploads\/sites\/10\/2026\/06\/hero-4-1024x683.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"683\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Dr. Imad Moustafa\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Imad Moustafa\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tahmini okuma s\u00fcresi\" \/>\n\t<meta name=\"twitter:data2\" content=\"20 dakika\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/elithair.com\\\/tr\\\/clascoterone-sac-dokulmesi\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/elithair.com\\\/tr\\\/clascoterone-sac-dokulmesi\\\/\"},\"author\":{\"name\":\"Dr. Imad Moustafa\",\"@id\":\"https:\\\/\\\/elithair.com\\\/tr\\\/#\\\/schema\\\/person\\\/11ce37e83a6343e4c37edcd4b5498e41\"},\"headline\":\"Sa\u00e7 d\u00f6k\u00fclmesi ilac\u0131 Clascoterone: Etkisi, \u00e7al\u0131\u015fmalar ve 2026 durumu\",\"datePublished\":\"2026-06-24T12:38:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/elithair.com\\\/tr\\\/clascoterone-sac-dokulmesi\\\/\"},\"wordCount\":4021,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/elithair.com\\\/tr\\\/clascoterone-sac-dokulmesi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/elithair.com\\\/tr\\\/wp-content\\\/uploads\\\/sites\\\/10\\\/2026\\\/06\\\/hero-4.png\",\"articleSection\":[\"Sa\u00e7 Ekimi\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/elithair.com\\\/tr\\\/clascoterone-sac-dokulmesi\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/elithair.com\\\/tr\\\/clascoterone-sac-dokulmesi\\\/\",\"url\":\"https:\\\/\\\/elithair.com\\\/tr\\\/clascoterone-sac-dokulmesi\\\/\",\"name\":\"Sa\u00e7 d\u00f6k\u00fclmesi ilac\u0131 Clascoterone (Breezula): Etkisi, yan etkileri, \u00e7al\u0131\u015fmalar ve bulunabilirlik | Elithair\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/elithair.com\\\/tr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/elithair.com\\\/tr\\\/clascoterone-sac-dokulmesi\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/elithair.com\\\/tr\\\/clascoterone-sac-dokulmesi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/elithair.com\\\/tr\\\/wp-content\\\/uploads\\\/sites\\\/10\\\/2026\\\/06\\\/hero-4.png\",\"datePublished\":\"2026-06-24T12:38:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/elithair.com\\\/tr\\\/#\\\/schema\\\/person\\\/11ce37e83a6343e4c37edcd4b5498e41\"},\"description\":\"Sa\u00e7 d\u00f6k\u00fclmesi ilac\u0131 Clascoterone (Breezula): etkisi, yan etkileri, Faz III \u00e7al\u0131\u015fmalar\u0131, Finasterid ile kar\u015f\u0131la\u015ft\u0131rmas\u0131 ve T\u00fcrkiye'de bulunup bulunmad\u0131\u011f\u0131.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/elithair.com\\\/tr\\\/clascoterone-sac-dokulmesi\\\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/elithair.com\\\/tr\\\/clascoterone-sac-dokulmesi\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\\\/\\\/elithair.com\\\/tr\\\/clascoterone-sac-dokulmesi\\\/#primaryimage\",\"url\":\"https:\\\/\\\/elithair.com\\\/tr\\\/wp-content\\\/uploads\\\/sites\\\/10\\\/2026\\\/06\\\/hero-4.png\",\"contentUrl\":\"https:\\\/\\\/elithair.com\\\/tr\\\/wp-content\\\/uploads\\\/sites\\\/10\\\/2026\\\/06\\\/hero-4.png\",\"width\":1536,\"height\":1024,\"caption\":\"Mann tr\u00e4gt eine klare topische L\u00f6sung mit einer Pipette auf den Haaransatz auf\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/elithair.com\\\/tr\\\/clascoterone-sac-dokulmesi\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/elithair.com\\\/tr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sa\u00e7 d\u00f6k\u00fclmesi ilac\u0131 Clascoterone: Etkisi, \u00e7al\u0131\u015fmalar ve 2026 durumu\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/elithair.com\\\/tr\\\/#website\",\"url\":\"https:\\\/\\\/elithair.com\\\/tr\\\/\",\"name\":\"Elithair\",\"description\":\"Elithair: sa\u00e7\u0131n\u0131z i\u00e7in en iyi klini\u011fi ke\u015ffedin\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/elithair.com\\\/tr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/elithair.com\\\/tr\\\/#\\\/schema\\\/person\\\/11ce37e83a6343e4c37edcd4b5498e41\",\"name\":\"Dr. Imad Moustafa\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9190499f6f3008cd7da57b179f07bfea4b4e382c816ba3e0de68db0b5a70c07d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9190499f6f3008cd7da57b179f07bfea4b4e382c816ba3e0de68db0b5a70c07d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9190499f6f3008cd7da57b179f07bfea4b4e382c816ba3e0de68db0b5a70c07d?s=96&d=mm&r=g\",\"caption\":\"Dr. Imad Moustafa\"},\"url\":\"https:\\\/\\\/elithair.com\\\/tr\\\/author\\\/support\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Sa\u00e7 d\u00f6k\u00fclmesi ilac\u0131 Clascoterone (Breezula): Etkisi, yan etkileri, \u00e7al\u0131\u015fmalar ve bulunabilirlik | Elithair","description":"Sa\u00e7 d\u00f6k\u00fclmesi ilac\u0131 Clascoterone (Breezula): etkisi, yan etkileri, Faz III \u00e7al\u0131\u015fmalar\u0131, Finasterid ile kar\u015f\u0131la\u015ft\u0131rmas\u0131 ve T\u00fcrkiye'de bulunup bulunmad\u0131\u011f\u0131.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/elithair.com\/tr\/clascoterone-sac-dokulmesi\/","og_locale":"tr_TR","og_type":"article","og_title":"Sa\u00e7 d\u00f6k\u00fclmesi ilac\u0131 Clascoterone: Etkisi, \u00e7al\u0131\u015fmalar ve 2026 durumu","og_description":"Sa\u00e7 d\u00f6k\u00fclmesi ilac\u0131 Clascoterone (Breezula): etkisi, yan etkileri, Faz III \u00e7al\u0131\u015fmalar\u0131, Finasterid ile kar\u015f\u0131la\u015ft\u0131rmas\u0131 ve T\u00fcrkiye'de bulunup bulunmad\u0131\u011f\u0131.","og_url":"https:\/\/elithair.com\/tr\/clascoterone-sac-dokulmesi\/","og_site_name":"Elithair","article_published_time":"2026-06-24T12:38:08+00:00","og_image":[{"width":1024,"height":683,"url":"https:\/\/elithair.com\/tr\/wp-content\/uploads\/sites\/10\/2026\/06\/hero-4-1024x683.png","type":"image\/png"}],"author":"Dr. Imad Moustafa","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Dr. Imad Moustafa","Tahmini okuma s\u00fcresi":"20 dakika"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/elithair.com\/tr\/clascoterone-sac-dokulmesi\/#article","isPartOf":{"@id":"https:\/\/elithair.com\/tr\/clascoterone-sac-dokulmesi\/"},"author":{"name":"Dr. Imad Moustafa","@id":"https:\/\/elithair.com\/tr\/#\/schema\/person\/11ce37e83a6343e4c37edcd4b5498e41"},"headline":"Sa\u00e7 d\u00f6k\u00fclmesi ilac\u0131 Clascoterone: Etkisi, \u00e7al\u0131\u015fmalar ve 2026 durumu","datePublished":"2026-06-24T12:38:08+00:00","mainEntityOfPage":{"@id":"https:\/\/elithair.com\/tr\/clascoterone-sac-dokulmesi\/"},"wordCount":4021,"commentCount":0,"image":{"@id":"https:\/\/elithair.com\/tr\/clascoterone-sac-dokulmesi\/#primaryimage"},"thumbnailUrl":"https:\/\/elithair.com\/tr\/wp-content\/uploads\/sites\/10\/2026\/06\/hero-4.png","articleSection":["Sa\u00e7 Ekimi"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/elithair.com\/tr\/clascoterone-sac-dokulmesi\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/elithair.com\/tr\/clascoterone-sac-dokulmesi\/","url":"https:\/\/elithair.com\/tr\/clascoterone-sac-dokulmesi\/","name":"Sa\u00e7 d\u00f6k\u00fclmesi ilac\u0131 Clascoterone (Breezula): Etkisi, yan etkileri, \u00e7al\u0131\u015fmalar ve bulunabilirlik | Elithair","isPartOf":{"@id":"https:\/\/elithair.com\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/elithair.com\/tr\/clascoterone-sac-dokulmesi\/#primaryimage"},"image":{"@id":"https:\/\/elithair.com\/tr\/clascoterone-sac-dokulmesi\/#primaryimage"},"thumbnailUrl":"https:\/\/elithair.com\/tr\/wp-content\/uploads\/sites\/10\/2026\/06\/hero-4.png","datePublished":"2026-06-24T12:38:08+00:00","author":{"@id":"https:\/\/elithair.com\/tr\/#\/schema\/person\/11ce37e83a6343e4c37edcd4b5498e41"},"description":"Sa\u00e7 d\u00f6k\u00fclmesi ilac\u0131 Clascoterone (Breezula): etkisi, yan etkileri, Faz III \u00e7al\u0131\u015fmalar\u0131, Finasterid ile kar\u015f\u0131la\u015ft\u0131rmas\u0131 ve T\u00fcrkiye'de bulunup bulunmad\u0131\u011f\u0131.","breadcrumb":{"@id":"https:\/\/elithair.com\/tr\/clascoterone-sac-dokulmesi\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/elithair.com\/tr\/clascoterone-sac-dokulmesi\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/elithair.com\/tr\/clascoterone-sac-dokulmesi\/#primaryimage","url":"https:\/\/elithair.com\/tr\/wp-content\/uploads\/sites\/10\/2026\/06\/hero-4.png","contentUrl":"https:\/\/elithair.com\/tr\/wp-content\/uploads\/sites\/10\/2026\/06\/hero-4.png","width":1536,"height":1024,"caption":"Mann tr\u00e4gt eine klare topische L\u00f6sung mit einer Pipette auf den Haaransatz auf"},{"@type":"BreadcrumbList","@id":"https:\/\/elithair.com\/tr\/clascoterone-sac-dokulmesi\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/elithair.com\/tr\/"},{"@type":"ListItem","position":2,"name":"Sa\u00e7 d\u00f6k\u00fclmesi ilac\u0131 Clascoterone: Etkisi, \u00e7al\u0131\u015fmalar ve 2026 durumu"}]},{"@type":"WebSite","@id":"https:\/\/elithair.com\/tr\/#website","url":"https:\/\/elithair.com\/tr\/","name":"Elithair","description":"Elithair: sa\u00e7\u0131n\u0131z i\u00e7in en iyi klini\u011fi ke\u015ffedin","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/elithair.com\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/elithair.com\/tr\/#\/schema\/person\/11ce37e83a6343e4c37edcd4b5498e41","name":"Dr. Imad Moustafa","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/9190499f6f3008cd7da57b179f07bfea4b4e382c816ba3e0de68db0b5a70c07d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9190499f6f3008cd7da57b179f07bfea4b4e382c816ba3e0de68db0b5a70c07d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9190499f6f3008cd7da57b179f07bfea4b4e382c816ba3e0de68db0b5a70c07d?s=96&d=mm&r=g","caption":"Dr. Imad Moustafa"},"url":"https:\/\/elithair.com\/tr\/author\/support\/"}]}},"_links":{"self":[{"href":"https:\/\/elithair.com\/tr\/wp-json\/wp\/v2\/posts\/83217","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/elithair.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/elithair.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/elithair.com\/tr\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/elithair.com\/tr\/wp-json\/wp\/v2\/comments?post=83217"}],"version-history":[{"count":0,"href":"https:\/\/elithair.com\/tr\/wp-json\/wp\/v2\/posts\/83217\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/elithair.com\/tr\/wp-json\/wp\/v2\/media\/83216"}],"wp:attachment":[{"href":"https:\/\/elithair.com\/tr\/wp-json\/wp\/v2\/media?parent=83217"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/elithair.com\/tr\/wp-json\/wp\/v2\/categories?post=83217"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/elithair.com\/tr\/wp-json\/wp\/v2\/tags?post=83217"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}